
Aqemia is a next-gen pharmatech company focused on drug discovery using quantum-inspired physics algorithms to power generative AI. The company designs innovative drug candidates for critical diseases like immuno-oncology without relying on experimental data, achieving several successes internally and through collaborations. Aqemia is part of the French Tech 120 program and has offices in Paris and London.
Aqemia is a next-generation pharmatech company reinventing drug discovery with quantum-inspired physics and generative AI. They work with scientists and engineers to operate and improve data flows used in their research, ensuring high data quality and seamless integration of experimental results with computational discovery. They are seeking an Intermediate Data Engineer to operate and maintain data pipelines.
Aqemia is a next-gen pharmatech company focused on drug discovery using quantum-inspired physics algorithms to power generative AI. The company designs innovative drug candidates for critical diseases like immuno-oncology without relying on experimental data, achieving several successes internally and through collaborations. Aqemia is part of the French Tech 120 program and has offices in Paris and London.